Synapse - JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management

JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management Meeting Abstract

Authors:	Gupta, S.; Cheville, J.; Jungbluth, A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S.; Fine, S.; Gopalan, A.; Al-Ahmadie, H.; Sirintrapun, S. J.; Blum, K.; Lohse, C.; Hakimi, A.; Thompson, R. H.; Leibovich, B.; Berger, M.; Arcila, M.; Ross, D.; Ladanyi, M.; Antonescu, C.; Reuter, V.
Abstract Title:	JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management
Meeting Title:	108th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title:	Laboratory Investigation
Volume:	99
Issue:	Suppl. 1
Meeting Dates:	2019 Mar 16-21
Meeting Location:	National Harbor, MD
ISSN:	0023-6837
Publisher:	Nature Publishing Group
Date Published:	2019-03-01
Start Page:	63
End Page:	64
Language:	English
ACCESSION:	WOS:000478081101319
PROVIDER:	wos
PUBMED:	30886261
DOI:	10.1038/s41374-019-0214-0
Notes:	Meeting Abstract: 855 -- Source: Wos